India pivotal to global fightback against AIDS, says chief o
With 2 million new HIV infections reported every year across the world and Indian companies supplying 66 per cent of antiretroviral drugs, the country is key to the global fightback against AIDS, Dr Mark Feinberg, president and CEO of the International AIDS Vaccine Initiative (IAVI), said on Monday.

Feinberg, currently on a visit to India, did not hazard a deadline for an AIDS vaccine but said work on it has improved understanding of the immune system and spawned many technologies that can help fight other diseases, including emerging threats such as Ebola and Zika.

A nonprofit scientific research organisation seeking to address urgent, unmet global health challenges — including HIV and tuberculosis — IAVI has several technology and innovation partnerships with the Department of Biotechnology.

“Making low-cost, high-quality antiretroviral drugs available is key to the global AIDS fightback. That is why Indian pharmaceutical companies, with their ability to manufacture high-quality, affordable medicines are key,” Feinberg told The Indian Express.

With neither a vaccine nor any cure in sight, antiretroviral therapy (ART) is the only option available for people living with HIV-AIDS. According to the World Health Organization, standard ART consists of a combination of at least three antiretroviral drugs to suppress the HIV virus and stop the progression of the disease.

S●●●●●●a Y●●●●●●u and 1 others like this